Loading…
Elicio Therapeutics, Inc. is projected to rise to $16.56 by 2027, a +54% move from its current price of $10.77. ELTX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $10.27 | $10.77 | $11.30 | +0.01% |
| May 30 | $10.07 | $10.77 | $11.52 | +0.03% |
| May 31 | $9.92 | $10.77 | $11.70 | +0.04% |
| Jun 1 | $9.80 | $10.78 | $11.85 | +0.06% |
| Jun 2 | $9.69 | $10.78 | $11.99 | +0.07% |
| Jun 3 | $9.59 | $10.78 | $12.11 | +0.08% |
| Jun 4 | $9.50 | $10.78 | $12.23 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.50 | $10.78 | $12.23 | +0.10% |
| Week 2 | $9.03 | $10.79 | $12.90 | +0.20% |
| Week 3 | $8.68 | $10.80 | $13.44 | +0.30% |
| Week 4 | $8.40 | $10.81 | $13.91 | +0.40% |
| Week 5 | $8.17 | $10.82 | $14.34 | +0.49% |
| Week 6 | $7.96 | $10.83 | $14.75 | +0.59% |
| Week 7 | $7.77 | $10.84 | $15.13 | +0.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company focused on immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations.
The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant BRAF-driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
ELTX is the ticker for Elicio Therapeutics, Inc., a clinical-stage biotechnology company focused on cancer immunotherapies.
A major floor 37.0% below — a decisive break under it would weaken the trend.
The nearest floor, 14.9% below — buyers have tended to step in here.
The nearest ceiling, 25.8% above — a clean break opens room to run.
A major ceiling 44.3% above — clearing it would confirm fresh momentum.
Key ELTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ELTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.12 | Buy | $10.24 | Buy |
| MA 10 | $10.22 | Buy | $10.24 | Buy |
| MA 20 | $10.39 | Buy | $10.44 | Buy |
| MA 50 | $10.88 | Sell | $10.61 | Buy |
| MA 100 | $10.12 | Buy | $10.31 | Buy |
| MA 200 | $9.92 | Buy | $9.71 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.92 | Neutral |
| Stoch RSI (14) | 78.03 | Neutral |
| CCI (20) | 54.50 | Neutral |
| Williams %R (14) | -34.43 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 8.68 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 65.57 | Neutral |
| TRIX (15) | -0.36 | Sell |
| Awesome (5,34) | -0.78 | Sell |
| Ultimate (7,14,28) | 50.81 | Neutral |
| Momentum (10) | 0.22 | Buy |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 10.21 | Buy |
| ADX (14) | 11.39 | Neutral |
| ATR (14) | 0.46 | Info |
The stock trades at $10.77 per share and has a market capitalization of $205.56M, with a rank of 3,787.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.60 | $10.77 | $16.90 | 0% | Neutral | |
| $12.18 | $16.56 | $24.28 | +54% | Bullish | |
| $12.40 | $17.74 | $27.51 | +65% | Bullish | |
| $13.10 | $19.59 | $31.74 | +82% | Bullish | |
| $14.00 | $21.80 | $36.63 | +102% | Bullish | |
| $15.50 | $25.05 | $43.43 | +133% | Bullish | |
| $21.55 | $36.08 | $64.33 | +235% | Bullish | |
| $24.33 | $42.13 | $77.05 | +291% | Bullish | |
| $26.71 | $47.81 | $89.47 | +344% | Bullish | |
| $29.25 | $54.05 | $103.33 | +402% | Bullish | |
| $45.69 | $98.38 | $205.32 | +813% | Bullish | |
| $74.38 | $165.30 | $380.18 | +14.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.60 | $10.77 | $12.73 | +0.00% |
| June 2026 | $8.80 | $10.50 | $12.95 | -2.51% |
| July 2026 | $9.00 | $10.91 | $13.77 | +3.90% |
| August 2026 | $9.26 | $11.35 | $14.58 | +4.05% |
| September 2026 | $8.94 | $11.07 | $14.42 | -2.44% |
| October 2026 | $8.94 | $11.17 | $14.73 | +0.86% |
| November 2026 | $9.59 | $12.08 | $16.11 | +8.18% |
| December 2026 | $9.88 | $12.54 | $16.90 | +3.80% |
Click any year to see its month-by-month ELTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Elicio Therapeutics, Inc.'s 2026 outlook centres on $10.77, within a $7.60 to $16.90 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ELTX could reach as high as $24.28, with a base case around $16.56 and support toward $12.18 — roughly +54% from $10.77. Buyers look set to stay in control over this stretch.
Expect ELTX to range from $12.40 to $27.51 through 2028. The $17.74 average target implies a +65% move from current prices. That is up +7% on the projected 2027 average. Momentum favours further upside here.
The ELTX price prediction for 2029 points to an average of $19.59 (low $13.10, high $31.74) — a potential gain of +82% on today's $10.77. Buyers look set to stay in control over this stretch.
In 2030, ELTX is projected to trade between $14.00 and $36.63, averaging $21.80 — a potential gain of +102% from today's $10.77. That is up +11% on the projected 2029 average. Momentum favours further upside here.
Elicio Therapeutics, Inc.'s 2031 outlook centres on $25.05, within a $15.50 to $43.43 range. That is up +15% on the projected 2030 average. That marks a +133% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ELTX could reach as high as $64.33, with a base case around $36.08 and support toward $21.55 — roughly +235% from $10.77. Momentum favours further upside here.
Expect ELTX to range from $24.33 to $77.05 through 2033. The $42.13 average target implies a +291% move from current prices. That is up +17% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ELTX price prediction for 2034 points to an average of $47.81 (low $26.71, high $89.47) — a potential gain of +344% on today's $10.77. Momentum favours further upside here.
In 2035, ELTX is projected to trade between $29.25 and $103.33, averaging $54.05 — a potential gain of +402% from today's $10.77. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Elicio Therapeutics, Inc.'s 2040 outlook centres on $98.38, within a $45.69 to $205.32 range. That is up +82% on the projected 2035 average. That marks a +813% change versus current levels. Momentum favours further upside here.
By 2050, ELTX could reach as high as $380.18, with a base case around $165.30 and support toward $74.38 — roughly +14.3x from $10.77. Buyers look set to stay in control over this stretch.
Investing $1,000 in ELTX today (≈ 92.850511 ELTX) could be worth
$15,347.88
+$14,347.88 (+1435%) by 2050 · US Dollar
Based on the average projected ELTX price of $165.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ELTXwould be worth at today's price.
$1,000 invested in ELTX on May 27, 2025 (≈ 158.478607 ELTX) would be worth
$1,706.81
+$706.81 (+70.7%) today · 1.71× · US Dollar
Based on a ELTX entry price of $6.31 vs. today's $10.77.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.97 | $1,080.24 | +8.0% |
| 1 month ago | $11.36 | $948.06 | -5.2% |
| 3 months ago | $11.74 | $917.38 | -8.3% |
| 6 months ago | $9.36 | $1,150.64 | +15.1% |
| 1 year ago | $6.31 | $1,706.81 | +70.7% |
| All time (5.0y) ago | $148.9 | $72.33 | -92.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ELTX forecast.
Our base-case forecast reaches $22.00 around 2031.
Implied market cap at $22.00: $419.89M
The multi-year forecast shows bullish sentiment in the later years, with 2026 (avg $10.77, min $7.60, max $16.90) and 2027 (avg $16.56, min $12.18, max $24.28) signaling upside potential. By 2030, the avg price is projected to $21.80 with a 102.4% ROI, and by 2040 the avg price is $98.38 with an 813.4% ROI. In 2050, the avg price is $165.30 with a 1434.8% ROI.
Across the forecast horizon, sentiment shifts to bullish from 2027 onward, culminating in a strongly bullish stance by 2050. These are estimates, not guarantees, and reflect potential upside alongside inherent investment uncertainty.
Tap a question to reveal the answer.
2030 avg $21.80; min $14.00; max $36.63; ROI 102.4%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with 2030 avg $21.80 and 2050 avg $165.30, and ROI rising to 1434.8% by 2050. 2026 is neutral.
Yes. The forecast max includes $103.33 in 2035 and $205.32 in 2040.
Current price is $10.77; market cap is $205.56M; rank is 3,787.
30-day range low $7.87; high $14.74.
Elicio Therapeutics, Inc. Community Discussion
0Share your Elicio Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.